SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-030228
Filing Date
2023-08-25
Accepted
2023-08-25 16:15:20
Documents
12
Period of Report
2023-08-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39700
  Complete submission text file 0001493152-23-030228.txt   218013

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rnxt-20230821.xsd EX-101.SCH 3015
3 XBRL LABEL FILE rnxt-20230821_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE rnxt-20230821_pre.xml EX-101.PRE 22789
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3568
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 231208434
SIC: 2834 Pharmaceutical Preparations